We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GOOGL:NASDAQAlphabet Inc. Analysis

Data as of 2026-09-04 - not real-time

$338.58

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $338.57, Alphabet Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 5.9%. Momentum indicators put RSI at 44.9 (neutral) with MACD reading bearish. Price has been bracketed by support at $332.82 and resistance at $357.61.
Multiples put this in fair territory: 17.0 times earnings against the sector's 15.5. Consensus targets land 26.4% above where the shares trade now. Revenue is growing at 24.2% on a 54.8% profit margin. The 0.26% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 33.9%, a beta of 1.36 and a maximum drawdown of 21.1%, position sizing matters here. The wider market backdrop reads extreme greed at 97 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top Market Events

Alphabet stock is steady with Q2 2026 earnings up more than 200% year over year, revenue growing aboAlex Sirois Fri, September 4, 2026 at 3:50 PM UTC 0 Quick Read - GOOGL trades at a P/E of 15 despite 82% Cloud revenue...Alphabet stock is trading near $332 after a July 23, 2026 quarter with revenue of $119.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 335.94
  • MACD momentum is negative
  • 30-day price change of +5.9%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 17.0 versus sector average of 15.5
  • Trading above the 200-day average of 335.94
  • Analyst targets imply +26.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 17.0 versus sector average of 15.5
  • Analyst targets imply +26.4% versus the current price
  • Profit margin of 54.8% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth24.20%
Profit Margin54.77%
P/E Ratio17.0
ROE48.68%
ROA12.96%
Debt/Equity18.86
P/B Ratio6.7
Op. Cash Flow$185.7B
Free Cash Flow$22.7B
Industry P/E15.5

Technical Analysis

TrendNeutral
RSI44.9
Support$332.82
Resistance$357.61
MA 20$343.62
MA 50$348.57
MA 200$335.94
MACDBearish
VolumeIncreasing
Fear & Greed Index96.55

Valuation

Fair Value$71.84
Target Price$428.07
Upside/Downside26.43%
GradeFair
TypeGrowth
Dividend Yield0.26%

Risk Assessment

Beta1.36
Volatility33.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.